期刊文献+

PD-1及其配体在原发性干燥综合征患者唇腺中的表达及临床意义 被引量:7

Expression and clinical significance of PD-1 and its ligands in salivary glands of patients with Sjogren's syndrome
下载PDF
导出
摘要 目的:观察干燥综合征(Sjogren's syndrome,SS)患者唇腺活检组织中程序性死亡分子-1(programmed death-1,PD-1)、程序性死亡配体-1(programmed death ligand-1,PD-L1)、程序性死亡配体-2(programmed death ligand-2,PD-L2)的表达,以及其与临床病理特征的相关性。方法:对所有患者和正常对照组的唇腺活检标本进行HE染色观察淋巴细胞浸润程度,免疫组织化学观察PD-1,PD-L1和PD-L2的表达。结果:SS患者唇腺活检组织中PD-1,PD-L1和PD-L2的表达较正常对照组明显增强。SS患者唇腺活检标本淋巴细胞的浸润程度与PD-1和PD-L2的表达强度无明显相关性,与PD-L1的表达强度呈正相关。SS患者疾病活动度评分与PD-1,PD-L1及PD-L2的表达强度均无明显相关性。SS患者疾病损害评分与PD-1的表达强度无明显相关性,与PD-L1和PD-L2的表达强度呈负相关。结论:PD-1,PD-L1及PD-L2在SS患者唇腺活检组织中的表达明显增强,PD-1/PD-L信号通路可能在SS的免疫病理损害中起重要作用。 Objective:To investigate the expression and its relativity with the clinicopathological characteristics of programmed death-1(PD-1) and its ligands PD-L1 and PD-L2 in salivary glands of patients with Sjogren's sy ndrome(SS).Methods:We used HE staining to obser ve the ly mphoc y te infiltration while used immunohistochemistry to observe the expression of PD-1,PD-L1 and PD-L2 in both patients' and normalcontrolled group's salivary glands biopsies.Results:The expression of PD-1,PD-L1 and PD-L2 in salivary glands biopsies of patients with SS significantly enhanced compared with the normal-controlled group.There were no significant relevance between the lymphocyte infiltration and the expression degrees of PD-1 and PD-L2 in salivary glands biopsies of patients with SS.However,lymphocyte infiltration had positive correlation with the expression degrees of PD-L1 in salivary glands biopsies of patients with SS.There were no significant relevance between the disease activity index of patients with SS and the expression degree of PD-1,PD-L1 and PD-L2.There was no significant relevance between the disease damage index of patients with SS and the expression degree of PD-1,while the disease damage index was negatively correlated with the expression degree of PD-L1 and PDL2.Conclusion:The expression of PD-1,PD-L1 and PD-L2 significantly enhance in salivary glands biopsies of patients with SS.Therefore,PD-1/PD-L pathway may play a big role in immune pathological damage of SS.
作者 杨月 侯佳奇 李国陵 薛鸾 张树辉 YANG Yue HOUJiaqi LI Guoling XUE Luan ZHANG Shuhui(Department of Rheumatology, Yueyang Hospital of Integrated Chinese and Western Medicine Affiliated to Shanghai University of Chinese Medicine, Shanghai 200437, Chin)
出处 《临床与病理杂志》 2017年第3期456-461,共6页 Journal of Clinical and Pathological Research
基金 上海市卫生局课题(20111016)~~
关键词 原发性干燥综合征 程序性死亡分子-1 程序性死亡配体 Sjogren's syndrome programmed death-1 programmed death ligands
  • 相关文献

参考文献2

二级参考文献10

  • 1[1]Jacobsson LTH,Axell TE,Hansen BU,et al.Dry eyes and mouth:an epidemiological study in Sweden adult,with special reference to primary Sj gren's syndrome[J].J Autoimmun,1989,2:521.
  • 2[2]Tsubota K,Hirai S,King LS,et al.Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjgren's syndrome[J].Lancet,2001,357(9257):688-689.
  • 3[3]Hulkkonen J,Pertovaara M,Kantonen J,et al.Genetic association between interleukin-10 promoter region polymorphisms and primary sjogren's syndrome[J].Arthritis Rheum,2001,44(1):176-179.
  • 4[4]Witte T,Matthias T,Arnett FC,et al.IgA and IgG autoantibodies against α-Fodrin as markers for SS[J].J Rheumatol,2000,27(11):2617-2620.
  • 5[6]Zhu Z,Stevenson D,Schechter JE,et al.Prophylactic effect of IL-10 gene transfer on induced autoimmune dacryoadenitis[J].Invest Ophthalmol Vis Sci,2004,45(5):1375-1381.
  • 6[7]Koski H,Janin A,Humphreys-Beher MG,et al.Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjogren's syndrome[J].Clin Exp Rheumatol,2001,19(2):131-137.
  • 7[8]Pijpe J,Imhoff GW,Spijkervet FK,et al.Rituximab treatment in patients with primary Sjogren's syndrome:an open-label phase Ⅱ study[J].Arthritis Rheum,2005,52(9):2740-2750.
  • 8[9]Epratuzumab Steinfeld SD,Tant L,Burmester GR,et al.(humanised anti-CD22 antibody) in primary Sjogren's syndrome:an open-label phase Ⅰ/Ⅱ study[J].Arthritis Res Ther,2006,8(4):129.
  • 9[10]Mariette X,Ravaud P,Steinfeld S,et al.Inefficacy of infliximab in primary Sjogren's syndrome:results of the randomized,controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS)[J].Arthritis Rheum,2004,50(4):1270-1276.
  • 10赵岩,董怡.第八届干燥综合征国际专题会议纪要[J].中华内科杂志,2003,42(2):131-132. 被引量:25

共引文献144

同被引文献48

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部